Profil
Mr. Roy M.
Gonzales was previously employed as a Chief Financial & Accounting Officer by Ventyx Biosciences, Inc., a Vice President-Finance by Landos Biopharma, Inc., and a Vice President-Finance & SEC Reporting by Histogen, Inc. He received his undergraduate degree from Old Dominion University, an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from the University of California, Los Angeles.
Tidigare kända positioner av Roy Gonzales
| Företag | Position | Slut |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Finansdirektör/CFO | 2026-03-04 |
| LANDOS BIOPHARMA, INC. | Företagsledare/Principal | 2022-06-01 |
| HISTOGEN INC. | Företagsledare/Principal | 2021-09-01 |
Roy Gonzaless utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
















